These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7102092)

  • 21. A comparison of two approaches to the construction of models for quantal responses to mixtures of drugs.
    Plackett RL; Hewlett PS
    Biometrics; 1967 Mar; 23(1):27-44. PubMed ID: 6050470
    [No Abstract]   [Full Text] [Related]  

  • 22. PK/PD modelling and simulations: utility in drug development.
    Rajman I
    Drug Discov Today; 2008 Apr; 13(7-8):341-6. PubMed ID: 18405847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of hepatic drug metabolism. For a rationalization of a new molecular development].
    Le Dinh T; Christoforov B
    Therapie; 1994; 49(2):133-40. PubMed ID: 7817337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidimensional separation and hyphenated techniques in pharmaceutical research: practical considerations.
    Cheng X
    Drug Discov Today; 2004 Apr; 9(7):305-6. PubMed ID: 15037228
    [No Abstract]   [Full Text] [Related]  

  • 25. Quantitative high-throughput analysis of drugs in biological matrices by mass spectrometry.
    Hopfgartner G; Bourgogne E
    Mass Spectrom Rev; 2003; 22(3):195-214. PubMed ID: 12838545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new paradigm for drug discovery in tropical rainforests.
    Capson TL; Coley PD; Kursar TA
    Nat Biotechnol; 1996 Oct; 14(10):1200-2. PubMed ID: 9631071
    [No Abstract]   [Full Text] [Related]  

  • 27. New cell models and assays in cardiac safety profiling.
    Meyer T; Sartipy P; Blind F; Leisgen C; Guenther E
    Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):507-17. PubMed ID: 17696802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The physico-chemical and chemical evaluation of medicinal substances.
    Vogelenzang EH
    Pharm Weekbl; 1970 Mar; 105(12):333-7. PubMed ID: 5417308
    [No Abstract]   [Full Text] [Related]  

  • 29. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selection criteria for drug-like compounds.
    Muegge I
    Med Res Rev; 2003 May; 23(3):302-21. PubMed ID: 12647312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Open Field Test: reinventing the wheel.
    Stanford SC
    J Psychopharmacol; 2007 Mar; 21(2):134-5. PubMed ID: 17329288
    [No Abstract]   [Full Text] [Related]  

  • 32. [The current requirements for the preclinical study of the safety of new drugs].
    Arzamastsev EV; Liubimov BI
    Eksp Klin Farmakol; 1995; 58(3):7-12. PubMed ID: 7663306
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabonomics in pharmaceutical R&D.
    Lindon JC; Holmes E; Nicholson JK
    FEBS J; 2007 Mar; 274(5):1140-51. PubMed ID: 17298438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanosizing--oral formulation development and biopharmaceutical evaluation.
    Kesisoglou F; Panmai S; Wu Y
    Adv Drug Deliv Rev; 2007 Jul; 59(7):631-44. PubMed ID: 17601629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metal complexes in medicinal chemistry: new vistas and challenges in drug design.
    Thompson KH; Orvig C
    Dalton Trans; 2006 Feb; (6):761-4. PubMed ID: 16437168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drugs, their targets and the nature and number of drug targets.
    Imming P; Sinning C; Meyer A
    Nat Rev Drug Discov; 2006 Oct; 5(10):821-34. PubMed ID: 17016423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modelling of the blood-brain barrier in drug discovery and development.
    Cecchelli R; Berezowski V; Lundquist S; Culot M; Renftel M; Dehouck MP; Fenart L
    Nat Rev Drug Discov; 2007 Aug; 6(8):650-61. PubMed ID: 17667956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of some pharmacological methods used in safety pharmacology studies.
    Pugsley MK
    Proc West Pharmacol Soc; 2004; 47():18-22. PubMed ID: 15633602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety evaluation to support First-In-Man investigations I: kinetic and safety pharmacology studies.
    Baldrick P
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):230-6. PubMed ID: 18501489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New technologies and screening strategies for hepatotoxicity: use of in vitro models.
    Dambach DM; Andrews BA; Moulin F
    Toxicol Pathol; 2005; 33(1):17-26. PubMed ID: 15805052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.